In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio

Tissue Engineering - Part A

Volumn 21, Issue 1-2, 2015, Pages 115-123

  Loebel, Claudia ^a   Czekanska, Ewa M ^a   Bruderer, Marco ^a   Salzmann, Gian ^b   Alini, Mauro ^a   Stoddart, Martin J ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; FLOWCHARTING; GENE EXPRESSION; MINERALOGY; STEM CELLS; TRANSCRIPTION;

CA INCORPORATION; EARLY INDICATORS; HUMAN MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC POTENTIAL; PROTEIN EXPRESSIONS; SCREENING METHODS;

CELL CULTURE;

CALCIUM 45; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; DEXAMETHASONE; MESSENGER RNA;

ARTICLE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; MINERALIZATION; OSTEOBLAST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; ADULT; AGED; CYTOLOGY; DONOR; DRUG EFFECTS; ELECTROPORATION; FEMALE; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEXAMETHASONE; DOWN-REGULATION; ELECTROPORATION; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOGENESIS; RNA, MESSENGER; RNA, SMALL INTERFERING; SOX9 TRANSCRIPTION FACTOR; TISSUE DONORS; YOUNG ADULT;

EID: 84921348590     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0096     Document Type: Article

References (27)

1. Lefebvre, V., and Smits, P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75, 200, 2005.
2. Zhao, Q., Eberspaecher, H., Lefebvre, V., and de Crom-brugghe B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209, 377, 1997.
3. Hattori, T., Muller, C., Gebhard, S., Bauer, E., Pausch, F., Schlund, B., Bosl, M.R., Hess, A., Surmann-Schmitt, C., von der Mark, H., de Crombrugghe, B., and von der Mark, K. SOX9 is a major negative regulator of cartilage vascu-larization, bone marrow formation and endochondral ossification. Development 137, 901, 2010.
4. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Kar-senty, G. Osf2/Cbfa1: a transcriptional activator of osteo-blast differentiation. Cell 89, 747, 1997.
5. Yamaguchi, A., Komori, T., and Suda, T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21, 393, 2000.
6. Ducy, P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219, 461, 2000.
7. Stricker, S., Fundele, R., Vortkamp, A., and Mundlos, S. Role of Runx genes in chondrocyte differentiation. Dev Biol 245, 95, 2002.
8. Akiyama, H., Kim, J.E., Nakashima, K., Balmes, G., Iwai, N., Deng, J.M., Zhang, Z., Martin, J.F., Behringer, R.R., Nakamura, T., and de Crombrugghe, B. Osteo-chon-droprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 102, 14665, 2005.
9. Zhou, G., Zheng, Q., Engin, F., Munivez, E., Chen, Y., Sebald, E., Krakow, D., and Lee, B. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 103, 19004, 2006.
10. Puleo, D.A., and Nanci, A. Understanding and controlling the bone-implant interface. Biomaterials 20, 2311, 1999.
11. Eames, B.F., and Helms, J.A. Conserved molecular program regulating cranial and appendicular skeletogenesis. Dev Dyn 231, 4, 2004.
12. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64, 295, 1997.
13. Lian, J.B., and Stein, G.S. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids). J Oral Implantol 19, 95, 1993.
14. Muraglia, A., Cancedda, R., and Quarto, R. Clonal mes-enchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7), 1161, 2000.
15. Marie, P.J., and Fromigue, O. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1, 539, 2006.
16. Shui, C., Spelsberg, T.C., Riggs, B.L., and Khosla, S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18, 213, 2003.
17. Hoemann, C.D., El-Gabalawy, H., and McKee, M.D. In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathol Biol (Paris) 57, 318, 2009.
18. Stockl, S., Gottl, C., Grifka, J., and Grassel, S. Sox9 modulates proliferation and expression of osteogenic markers of adipose-derived stem cells (ASC). Cell Physiol Biochem 31, 703, 2013.
19. Li, Z., Kupcsik, L., Yao, S.J., Alini, M., and Stoddart, M.J. Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites. Tissue Eng Part A 15, 1729, 2009.
20. Labarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102, 344, 1980.
21. Kupcsik, L., Meury, T., Flury, M., Stoddart, M., and Alini, M. Statin-induced calcification in human mesenchymal stem cells is celldeath related. J Cell Mol Med 13, 4465, 2009.
22. Cheng, A., and Genever, P.G. SOX9 determines RUNX2 transactivity by directing intracellular degradation. J Bone Miner Res 25, 2680, 2010.
23. Dimitriou, R., Tsiridis, E., and Giannoudis, P.V. Current concepts of molecular aspects of bone healing. Injury 36, 1392, 2005.
24. Tsiridis, E., Upadhyay, N., and Giannoudis, P. Molecular aspects of fracture healing: which are the important molecules? Injury 38 Suppl 1, S11, 2007.
25. Liang, B., Cotter, M.M., Chen, D., Hernandez, C.J., and Zhou, G. Ectopic expression of SOX9 in osteoblasts alters bone mechanical properties. Calcif Tissue Int 90, 76, 2012.
26. Zernike, F. Observing the phases of light waves. Science 107, 463, 1948.
27. Whitehead, K., Kish, A., Pan, M., Kaur, A., Reiss, D.J., King, N., Hohmann, L., DiRuggiero, J., and Baliga, N.S. An integrated systems approach for understanding cellular responses to gamma radiation. Mol Syst Biol 2, 47, 2006.